Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Meningitec

Meningitec

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Meningitec

12 trials tracked of Meningitec: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 68 citations.

12Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 8 Phase 2 4
  1. Phase 3 Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine Completed · 68 cited
  2. Phase 3 Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612 Completed
  3. Phase 3 Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. Completed
  4. Phase 3 Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children Completed
  5. Phase 3 Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines Completed
  6. Phase 3 Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC Completed
Show 6 more trials
  1. Phase 3 Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children Completed
  2. Phase 3 Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m Completed
  3. Phase 2 Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine Completed
  4. Phase 2 Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612 Completed
  5. Phase 2 Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines Completed
  6. Phase 2 Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.